Erin Cantu, PA
Medical · Monroe, LANPI 1184274185
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 180 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by Johnson & Johnson at 26.6% of the total. Reporting peaked in 2022 at $964 and has fallen 74.6% since, to $245 in 2025.
Across 180 payments — averaging $17.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$830
- Lilly USA, LLC$418
- Sanofi$398
- AbbVie$380
- Sun Pharmaceutical Industries Inc.$194
- Amgen$160
- plus $740 from 12 others
What the payments were for
- Food & beverage$3,120100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 50 | $830 |
| Lilly USA, LLC | 22 | $418 |
| Sanofi | 20 | $398 |
| AbbVie | 27 | $380 |
| Sun Pharmaceutical Industries Inc. | 14 | $194 |
| Amgen | 8 | $160 |
| Incyte Corporation | 7 | $133 |
| UCB, Inc. | 6 | $125 |
| LEO Pharma Inc. | 6 | $115 |
| Almirall LLC | 4 | $90 |
| Regeneron Healthcare Solutions, Inc. | 4 | $79 |
| Biofrontera Inc. | 4 | $46 |
| Arcutis Biotherapeutics, Inc. | 2 | $37 |
| Pfizer | 2 | $33 |
| Dermavant Sciences, Inc. | 1 | $24 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $21 |
| Boehringer Ingelheim | 1 | $21 |
| VYNE Pharmaceuticals Inc. | 1 | $16 |
How this compares
$3,120 in reported general payments places this provider in the 75th percentile of 253 medical providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorouracil | 39 | $2,612 |
| Mometasone Furoate | 80 | $1,499 |
| Metronidazole | 26 | $1,201 |
| Clobetasol Propionate | 38 | $1,109 |
| Betamethasone Dipropionate | 14 | $858 |
| Ketoconazole | 62 | $851 |
| Fluocinonide | 25 | $759 |
| Fluocinolone Acetonide | 13 | $495 |
| Hydrocortisone | 70 | $471 |
| Triamcinolone Acetonide | 44 | $407 |
| Minocycline Hcl | 18 | $229 |
| Nystatin | 23 | $223 |
| Doxycycline Hyclate | 15 | $206 |
| Mupirocin | 25 | $194 |
Paid to pharmacies, not to this prescriber.
Other medical in Monroe
- Leigh CordillMonroe$4K
- Kristi RobertBaton Rouge$486K
- Vickie RiceBaton Rouge$19K
- Mary McFerrenShreveport$16K
- Rachel RhinehartJefferson$16K
- Sydney FussellCovington$16K
- Thomas BriscoeLafayette$13K
- Seth HendrixShreveport$12K
- Jessica PelusoNatchitoches$12K
- Heather RoanBossier City$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.